These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19275555)

  • 1. Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: a review.
    Cruz AK; de Toledo JS; Falade M; Terrão MC; Kamchonwongpaisan S; Kyle DE; Uthaipibull C
    Curr Drug Targets; 2009 Mar; 10(3):178-92. PubMed ID: 19275555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products as trypanocidal, antileishmanial and antimalarial drugs.
    Fournet A; Muñoz V
    Curr Top Med Chem; 2002 Nov; 2(11):1215-37. PubMed ID: 12171582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
    Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
    Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent Progress in the Development of Indole-Based Compounds Active against Malaria, Trypanosomiasis and Leishmaniasis.
    Pacheco PAF; Santos MMM
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protozoan persister-like cells and drug treatment failure.
    Barrett MP; Kyle DE; Sibley LD; Radke JB; Tarleton RL
    Nat Rev Microbiol; 2019 Oct; 17(10):607-620. PubMed ID: 31444481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmaniasis drug discovery: recent progress and challenges in assay development.
    Zulfiqar B; Shelper TB; Avery VM
    Drug Discov Today; 2017 Oct; 22(10):1516-1531. PubMed ID: 28647378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput prioritization of target proteins for development of new antileishmanial compounds.
    Azevedo LG; Sosa E; de Queiroz ATL; Barral A; Wheeler RJ; Nicolás MF; Farias LP; Do Porto DF; Ramos PIP
    Int J Parasitol Drugs Drug Resist; 2024 Aug; 25():100538. PubMed ID: 38669848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnomedicines and anti-parasitic activities of Pakistani medicinal plants against Plasmodia and Leishmania parasites.
    Tariq A; Adnan M; Amber R; Pan K; Mussarat S; Shinwari ZK
    Ann Clin Microbiol Antimicrob; 2016 Sep; 15(1):52. PubMed ID: 27647140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapeutic targets for treatment of leishmaniasis.
    Sundar S; Singh B
    Expert Opin Ther Targets; 2018 Jun; 22(6):467-486. PubMed ID: 29718739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.
    Navarro M; Gabbiani C; Messori L; Gambino D
    Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear DNA replication and repair in parasites of the genus Leishmania: Exploiting differences to develop innovative therapeutic approaches.
    Uzcanga G; Lara E; Gutiérrez F; Beaty D; Beske T; Teran R; Navarro JC; Pasero P; Benítez W; Poveda A
    Crit Rev Microbiol; 2017 Mar; 43(2):156-177. PubMed ID: 27960617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and evaluation of Peruvian plants used to treat malaria and leishmaniasis.
    Kvist LP; Christensen SB; Rasmussen HB; Mejia K; Gonzalez A
    J Ethnopharmacol; 2006 Jul; 106(3):390-402. PubMed ID: 16517108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
    Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease.
    Witschel M; Rottmann M; Kaiser M; Brun R
    PLoS Negl Trop Dis; 2012; 6(10):e1805. PubMed ID: 23145187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
    Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
    Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.
    Charlton RL; Rossi-Bergmann B; Denny PW; Steel PG
    Parasitology; 2018 Feb; 145(2):219-236. PubMed ID: 28805165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery.
    das Neves GM; Kagami LP; Gonçalves IL; Eifler-Lima VL
    Future Med Chem; 2019 Aug; 11(16):2107-2130. PubMed ID: 31370699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania spp.: proficiency of drug-resistant parasites.
    Natera S; Machuca C; Padrón-Nieves M; Romero A; Díaz E; Ponte-Sucre A
    Int J Antimicrob Agents; 2007 Jun; 29(6):637-42. PubMed ID: 17353113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review.
    Passero LFD; Cruz LA; Santos-Gomes G; Rodrigues E; Laurenti MD; Lago JHG
    Curr Top Med Chem; 2018; 18(15):1275-1286. PubMed ID: 30277153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.